Difficulty: Medium
Average Score: 82%
Practice
Which of the following antienzymes is a carbonic anhydrase inhibitor?
Correct answer
D
Rationale
In the context of Lifespan Pharmacology, understanding the mechanism of action of different drugs is crucial for safe and effective prescribing. In this question, the correct answer is D) Acetazolamide, which is a carbonic anhydrase inhibitor. Acetazolamide works by inhibiting the enzyme carbonic anhydrase, leading to decreased production of bicarbonate ions in the kidneys, reducing intraocular pressure in the eyes, and helping with conditions like glaucoma and altitude sickness.
Now, let's analyze why the other options are incorrect:
A) Physostigmine: Physostigmine is a cholinesterase inhibitor used to treat anticholinergic toxicity or glaucoma. It does not inhibit carbonic anhydrase.
B) Selegiline: Selegiline is a monoamine oxidase inhibitor used in the treatment of Parkinson's disease. It does not inhibit carbonic anhydrase.
C) Aminocaproic acid: Aminocaproic acid is an antifibrinolytic agent used to treat excessive bleeding. It does not inhibit carbonic anhydrase.
Educationally, this question highlights the importance of understanding specific drug classes and their mechanisms of action. Knowing which enzymes or receptors a drug targets helps healthcare providers make informed decisions when selecting the most appropriate medication for a patient's condition. It also emphasizes the need for precision in pharmacological knowledge to ensure patient safety and optimal therapeutic outcomes.
Now, let's analyze why the other options are incorrect:
A) Physostigmine: Physostigmine is a cholinesterase inhibitor used to treat anticholinergic toxicity or glaucoma. It does not inhibit carbonic anhydrase.
B) Selegiline: Selegiline is a monoamine oxidase inhibitor used in the treatment of Parkinson's disease. It does not inhibit carbonic anhydrase.
C) Aminocaproic acid: Aminocaproic acid is an antifibrinolytic agent used to treat excessive bleeding. It does not inhibit carbonic anhydrase.
Educationally, this question highlights the importance of understanding specific drug classes and their mechanisms of action. Knowing which enzymes or receptors a drug targets helps healthcare providers make informed decisions when selecting the most appropriate medication for a patient's condition. It also emphasizes the need for precision in pharmacological knowledge to ensure patient safety and optimal therapeutic outcomes.